Cubist Systematic Strategies, LLC - GT BIOPHARMA INC ownership

GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 56 filers reported holding GT BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q2 2023$3,263
-98.6%
10,458
-69.0%
0.00%
-100.0%
Q3 2021$227,00033,7030.00%
Other shareholders
GT BIOPHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Baskin Financial Services Inc. 151,354$360.00%
Moss Adams Wealth Advisors LLC 20,000$4,8220.00%
UBS Group AG 8,750$2,1090.00%
Compagnie Lombard Odier SCmA 50,000$12,0550.00%
OSAIC HOLDINGS, INC. 1,270$3050.00%
FMR LLC 150$360.00%
BANK OF AMERICA CORP /DE/ 508$1220.00%
WELLS FARGO & COMPANY/MN 300,697$72,4980.00%
NORTHERN TRUST CORP 32,347$7,7990.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GT BIOPHARMA INC shareholders